Cardiovascular Systems/ US1416191062 /
2023-04-27 10:00:00 PM | Chg. - | Volume | Bid10:01:29 PM | Ask11:02:00 PM | High | Low |
---|---|---|---|---|---|---|
20.0000USD | - | 398,334 Turnover: 6.86 mill. |
19.9900Bid Size: 100 | 20.0000Ask Size: 2,300 | 20.0000 | 19.9800 |
GlobeNewswire
6:17 PM
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire
6:00 PM
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...
GlobeNewswire
1:30 PM
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology...
GlobeNewswire
1:03 PM
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National ...
GlobeNewswire
05-14
MEACOR Secures $15 Million in Series A Funding to Advance Innovative Transcatheter Heart Valve Repai...
GlobeNewswire
05-14
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
05-14
Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET...
Newsfile Corp
05-14
Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart ...
GlobeNewswire
05-14
New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Hear...
GlobeNewswire
05-13
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial...
GlobeNewswire
05-13
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
05-13
Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase...
GlobeNewswire
05-09
Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Prog...
GlobeNewswire
05-09
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
GlobeNewswire
05-08
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-08
Will your health insurance cover weight-loss medications? It depends on several factors, including w...
GlobeNewswire
05-08
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population ...
GlobeNewswire
05-08
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...
GlobeNewswire
05-08
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results